Evidence map›Paper›PMID 37394512›Full record

ArticlePediatrics2023

Building School-Academic Partnerships to Implement COVID-19 Testing in Underserved Populations.

Jennifer L Goldman, Ibukunoluwa C Kalu, Jennifer E Schuster, Tyler Erickson, Dana Keener Mast, Kanecia Zimmerman, Daniel K Benjamin, Luther G Kalb, Christina Gurnett, Jason G Newland and 32 more

Abstract read
In one paragraph

Article in Pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Jennifer L GoldmanDivision of Pediatric Infectious Diseases, Children's Mercy Kansas City, Kansas City, Missouri.
Ibukunoluwa C KaluDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Jennifer E SchusterDivision of Pediatric Infectious Diseases, Children's Mercy Kansas City, Kansas City, Missouri.
Tyler EricksonDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Dana Keener MastKennedy Krieger Institute, Baltimore, Maryland.
Kanecia ZimmermanDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Daniel K BenjaminDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Luther G KalbJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Christina GurnettDepartment of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
Jason G NewlandDepartment of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
Michael SherbyDepartment of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
Maya GodambeDepartment of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
Nidhi ShindeDepartment of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
Treymayne WattersonDepartment of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
Tyler WalshDepartment of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
John FoxeDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, 31 Baltimore, Maryland.
Martin ZandDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, 31 Baltimore, Maryland.
Stephen DewhurstDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, 31 Baltimore, Maryland.
Ryan CollerDepartment of Health Systems and Population Health, University of Washington School of Public Health, Seattle, Washington.
Gregory P DeMuriDepartment of Health Systems and Population Health, University of Washington School of Public Health, Seattle, Washington.
Shannon ArchuletaDepartment of Pediatrics, Washington University in St Louis, St Louis, Missouri.
Linda K KoFred Hutchinson Cancer Research Center, Seattle, Washington.
Moira InkelasCenter for Health Promotion and Disease Prevention, Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona.
Vladimir ManuelCenter for Health Promotion and Disease Prevention, Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona.
Rebecca Lee
Hyunsung OhCenter for Personalized Diagnostics, ASU Biodesign Clinical Testing Laboratory, Biodesign Institute, Arizona State University, Tempe, Arizona.
Vel MuruganDivision of Primary, Complex, and Adolescent Medicine, Phoenix Children's Hospital, Phoenix, Arizona.
Joanna KramerUniversity of Hawaii, Honolulu, Hawaii.
May OkihiroDepartment of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida.
Lisa GwynnUniversity of Nebraska Medical Center, Omaha, Nebraska.
Elizabeth PulgaronUniversity of Nebraska Medical Center, Omaha, Nebraska.
Russell McCullohDivision of Epidemiology and Biostatistics, San Diego State University School of Public Health, San Diego, California.
Jana BroadhurstDivision of Epidemiology and Biostatistics, San Diego State University School of Public Health, San Diego, California.
Corinne McDaniels-DavidsonDepartment of Dermatology, University of Utah, Salt Lake City, Utah.
Susan KieneDepartment of Dermatology, University of Utah, Salt Lake City, Utah.
Eyal OrenDepartment of Dermatology, University of Utah, Salt Lake City, Utah.
Yelena WuHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
David W WetterDepartment of Population Health Sciences, University of Utah, Salt Lake City, Utah.
Tammy StumpHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
M Alan BrookhartICF, Fairfax, Virginia.
Alex FistDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Emily HarozJohns Hopkins Center for Indigenous Health, Baltimore, Maryland.

Funding

COVID-19 Supplement - Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)U24TR001608 · NCATS · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K., HERNANDEZ, ADRIAN · 2016 to 2022
$177.0M
RADx-UP SAY YES COVID Test Study (S4)U24MD016258 · NIMHD · DUKE UNIVERSITY · PI COHEN-WOLKOWIEZ, MICHAEL, DAVE, GAURAV J · 2020 to 2023
$116.7M
Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
WUIDDRC Supplement-Supporting the health and well-being of children with intellectual and developmental disability during COVID-19 pandemicP50HD103525 · NICHD · WASHINGTON UNIVERSITY · PI JOSEPH D DOUGHERTY, Natasha Marrus · 2020 to 2026
$15.5M
Sleep and Circadian Dysfunction, Brain and Neurobehavioral Development in AutismP50HD103538 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI Stewart H Mostofsky · 2020 to 2026
$9.9M
SARS-CoV-2 Screening and Diagnostic testing for return to K-12 schoolsOT2HD107559 · NICHD · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K., ZIMMERMAN, KANECIA OBIE · 2021 to 2022
$5.0M
Support for Safe Return to in-Person School: COVID-19 Testing, Learning, and Consultation (School TLC)OT2HD107555 · NICHD · ICF MACRO, INC. · PI GOLDMAN, JENNIFER LYNN, KEENER MAST, DANA · 2021 to 2022
$5.0M
Project Safe Schools: Re-opening schools SAFELY for Native American youthOT2HD107543 · NICHD · JOHNS HOPKINS UNIVERSITY · PI BARLOW, MARY ALLISON, HAMMITT, LAURA · 2021 to 2022
$4.8M
Communities Fighting COVID!: Returning Our Kids Back to School SafelyOT2HD108112 · NICHD · SAN DIEGO STATE UNIVERSITY · PI KIENE, SUSAN MARIA, MCDANIELS, CORINNE RAE · 2021 to 2022
$4.0M
COV-IDD: Testing for COVID-19 in high risk children with intellectual and developmental disabilitiesOT2HD107553 · NICHD · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN, FOXE, JOHN J · 2021 to 2022
$4.0M
Using COVID-19 testing and risk communication strategies to accelerate students return to schoolOT2HD107544 · NICHD · UNIVERSITY OF WASHINGTON · PI KO, LINDA K. · 2021 to 2022
$4.0M
NCATS NIH HHS U24 TR001608NCATS NIH HHS UL1 TR002538NCATS NIH HHS UM1 TR004409NIAAA NIH HHS HHSN275201000003CNICHD NIH HHS HHSN275201000003INICHD NIH HHS OT2 HD107543NICHD NIH HHS OT2 HD107544NICHD NIH HHS OT2 HD107553NICHD NIH HHS OT2 HD107555NICHD NIH HHS OT2 HD107556NICHD NIH HHS OT2 HD107557NICHD NIH HHS OT2 HD107558NICHD NIH HHS OT2 HD107559NICHD NIH HHS OT2 HD108097NICHD NIH HHS OT2 HD108101NICHD NIH HHS OT2 HD108103NICHD NIH HHS OT2 HD108105NICHD NIH HHS OT2 HD108106NICHD NIH HHS OT2 HD108110NICHD NIH HHS OT2 HD108111NICHD NIH HHS OT2 HD108112NICHD NIH HHS P50 HD103525NICHD NIH HHS P50 HD103538NIMHD NIH HHS U24 MD016258
6 · The paper itself

Abstract

objectiveIn April 2021, the US government made substantial investments in students' safe return to school by providing resources for school-based coronavirus disease 2019 (COVID-19) mitigation strategies, including COVID-19 diagnostic testing. However, testing uptake and access among vulnerable children and children with medical complexities remained unclear.

methodsThe Rapid Acceleration of Diagnostics Underserved Populations program was established by the National Institutes of Health to implement and evaluate COVID-19 testing programs in underserved populations. Researchers partnered with schools to implement COVID-19 testing programs. The authors of this study evaluated COVID-19 testing program implementation and enrollment and sought to determine key implementation strategies. A modified Nominal Group Technique was used to survey program leads to identify and rank testing strategies to provide a consensus of high-priority strategies for infectious disease testing in schools for vulnerable children and children with medical complexities.

resultsAmong the 11 programs responding to the survey, 4 (36%) included prekindergarten and early care education, 8 (73%) worked with socioeconomically disadvantaged populations, and 4 focused on children with developmental disabilities. A total of 81 916 COVID-19 tests were performed. "Adapting testing strategies to meet the needs, preferences, and changing guidelines," "holding regular meetings with school leadership and staff," and "assessing and responding to community needs" were identified as key implementation strategies by program leads.

conclusionsSchool-academic partnerships helped provide COVID-19 testing in vulnerable children and children with medical complexities using approaches that met the needs of these populations. Additional work is needed to develop best practices for in-school infectious disease testing in all children.

Indexed as

COVID-19Vulnerable PopulationsChildCOVID-19 TestingHumansSchoolsStudents

Identifiers

PMID37394512
PMCPMC10312280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.